C‐reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

C‐reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma

Published:2019-07-24 Issue:10 Volume:26 Page:992-998
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Konishi Sakae¹,Hatakeyama Shingo¹,Tanaka Toshiaki²,Ikehata Yoshinori³,Tanaka Toshikazu¹,Hamano Itsuto¹,Fujita Naoki¹,Yoneyama Tohru¹,Yamamoto Hayato¹,Yoneyama Takahiro¹,Hashimoto Yasuhiro¹,Yoshikawa Kazuaki⁴,Kawaguchi Toshiaki⁵,Masumori Naoya²,Kitamura Hiroshi³,Ohyama Chikara¹

Affiliation:

1. Department of Urology Hirosaki University Graduate School of Medicine HirosakiJapan

2. Department of Urology Sapporo Medical University School of Medicine SapporoJapan

3. Department of Urology Graduate School of Medicine University of Toyama ToyamaJapan

4. Department of Urology Mutsu General Hospital MutsuJapan

5. Department of Urology Aomori Prefectural Central Hospital Aomori Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14078

Reference30 articles.

1. Current status of prognostic factors in patients with metastatic renal cell carcinoma

2. Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

3. Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives

4. Molecular-targeted therapy in advanced renal cell carcinoma based on pharmacokinetics, pharmacodynamics and pharmacogenetics: A proposed strategy

5. Tumor growth velocity: A modified tumor growth rate defining tumor progression during sorafenib treatment in patients with metastatic renal cell carcinoma

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Prognostic Variables for Overall Survival in Patients with Metastatic Renal Cell Carcinoma: A Meta-Analysis Of 29,366 Patients;JU Open Plus;2024-04

2. Systemic Inflammatory Markers Predicting the Overall Survival of Patients Using Tyrosine Kinase Inhibitors in the First-line Treatment of Metastatic Renal Cell Carcinoma;Journal of the College of Physicians and Surgeons Pakistan;2023-06-01

3. Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma;International Journal of Urology;2023-05-07

4. Evaluation of risk factors for COVID-19 severity or death and their relationship to metabolic pathways;Heliyon;2023-03

5. Is CRP/Albumin Ratio (CAR) a New Parameter to be Added to Risk Stratification Systems in Metastatic Renal Cell Carcinoma Patients?;Journal of the College of Physicians and Surgeons Pakistan;2022-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3